Video-Based Proprioceptive Exercise Program in ALS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorTarsus University

About this trial

In the project, it was aimed to evaluate the proprioceptive system in the disease, which is still mysterious and therefore has no curative treatment under current conditions, and to examine the effects of the video-based proprioceptive home exercise programme on trunk and limb control and daily life activity as well as trunk and limb control. The study was planned to include 20 patients with a definite diagnosis of ALS. Proprioceptive sensory examination will be performed again in these patients, who are currently being followed up with ALS diagnosis and whose physical examination including neurological examination has been performed in detail, and the "Revised Amyotrophic Lateral Sclerosis Functional Rating Scale" (R-ALSFRS) will be applied to the patients. Subsequently, the patients will be followed up by applying a video-based proprioceptive home exercise programme 3 days a week for 8 weeks. At the end of the 8th week, a detailed neurological examination including proprioceptive sensation will be performed and the R-ALSFRS scale will be applied. In addition, ALS quality of life scale will be applied to the patients before and after the home programme. The data obtained after the treatment programme will be analysed and interpreted.

Eligibility criteria

Qualifiers

ALS patients aged 18-70

Those with a definite ALS diagnosis according to the Gold Coast criteria

Those who can sit independently

Those who have no cognitive problems

Disqualifiers

ALS patients with neurological, orthopedic or visual dysfunction mimicking ALS,

Those who cannot complete active joint movements in the upper and lower extremities,

ALS patients who do not agree to participate in the study will not be included in the study.

Trial design

Treatments tested in this trial

  • video based exercise

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators

Tarsus University

Lead sponsor

The Scientific and Technological Research Council of Turkey

Collaborator